Our fantastic partnership with Fearsome featured in the latest edition of @ONdrugDelivery shares the development story behind our novel & highly-scalable platform for gene and cell therapy delivery. 🧬 #neurochase#fearsome#cell#gene#intraparenchymal
https://t.co/TzEi32cyXv
Wonderful feature sharing how Neurochase is transforming direct brain CED from the floor of #ASGCT2026 today. Many thanks to The Biotech Voyageur for stopping by our booth!
https://t.co/THyFTP3IEP
#neurosurgery#genetherapy@biotechvoyager
CED is evolving. Are you?🧠Join Neurochase at #ASGCT2026 (Booth #971) to see the nFuse™ System in action. Our 2-hour target-to-end, multi-infusion CED procedure is designed for existing robots & frames in the OR today.
📍 Poster 3478 📅 May 14, 5PM #GeneTherapy#Neurotwitter
Thrilled to welcome Dr. Max Woolley & Julia Williams to @Neurochase! Joining from Renishaw following our neuroinfuse™ acquisition, their expertise in drug delivery & R&D arrives as we prepare for clinical trials later this year. Welcome to the team! 🚀#NeuroTech#ClinicalTrials
Neurochase acquires Neuroinfuse™ drug delivery system & IP from Renishaw Neuro Solutions! 🧠 This advanced, chronic delivery system significantly boosts our portfolio for the £1.5B CNS market. Clinical trial planned for early 2026. https://t.co/kirsjqRs2e
#CNS#DIPG#CED#NSGY
Our Chief Marketing Officer @canuck1973 will be in Phoenix next week to attend the @alliancerm Cell & Gene Therapy Meeting on the Mesa. Connect with Jacquie to find out more about our effective, efficient and scalable medical device for targeted delivery to the CNS.
Meet @canuck1973 tomorrow at the 2nd Annual Gene Therapy Initiative Symposium hosted by @UCSanDiego at the @SalkInstitute in La Jolla, where we'll present a poster on the @neurochase acute drug delivery system. Details in link: https://t.co/UZ9y0DAXjR
Neurochase is expanding! This is an excellent opportunity for a Neuroscience BSc graduate in the UK to work closely with some of the world’s experts in intraparenchymal drug delivery. #UKTalent#NeuroscienceJobs#BiotechCareers#preclinical
Check it out! https://t.co/HMQzKcVLcJ
Our founder Professor Steven Gill will deliver an oral presentation at @ASGCTherapy annual conference tomorrow morning at 9.30 local time in the New Orleans Theatre. Don't miss it. You can also still visit us @ booth 1057. #ASGCT2025
What a fantastic response to our abstract poster presentation at @ASGCTherapy annual meeting last night. Oral presentation from our founder Prof. Steven Gill to come this Saturday at 8am in New Orleans Theater. Visit our booth 1057 this week for more. #ASGCT2025#CED
#ASGCT2025 just kicked off, stop by booth 1057 to learn how our next generation CNS delivery platform is designed to be the most efficient, effective, and scalable system available for pre-clinical and clinical trials.
#CED#genetherapy#celltherapy#neurosurgery
We will be at the @ASGCTherapy annual meeting next week to showcase our game-changing CED medical device, host an abstract poster and deliver an oral presentation. Visit booth 1057 to find out more about our pioneering work in drug delivery to the CNS. Details below.
6/11 @spark_tx enters into strategic collaboration with @neurochase to leverage delivery technology for gene therapies to treat central nervous system disorders.
https://t.co/IawwaanG6K
@john_weinhold@ClearPointNeuro Hi John, we look forward to further research comparing various CED systems in terms of accuracy & safety. It is yet to be determined if the benefits of MRI infusions outweigh the risks of repeat surgery for chronic delivery. We are excited to be apart of this burgeoning field.
Today is World Parkinson's Day and The Michael J. Fox Foundation's Day of Giving. By donating today, you are committing to help us push Parkinson's research forward. Tag us and share your story but don't forget to use #ParkinsonsAwarenessMonth. Give today: https://t.co/nD9qsD87Gy